# Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion

> **NCT04061473** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 20 (actual)

## Conditions studied

- Diabetes After Total Pancreatectomy

## Interventions

- **DRUG:** Sitagliptin 100mg
- **DRUG:** Empagliflozin 25 MG
- **OTHER:** Placebo tablet

## Key facts

- **NCT ID:** NCT04061473
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-02
- **Primary completion:** 2019-08-20
- **Final completion:** 2019-08-20
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04061473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04061473, "Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT04061473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*